Form D · Pharmaceuticals

Aarden Pharmaceuticals, Inc.

Indianapolis, IN · CIK 0001507273

Offering snapshot reported Jan 3, 2011 · SEC filing

Reported sold
$500K
Offering amount: $500K
Investors reported
2
Form D · investor count
Minimum accepted
$250K
Reported outside-investor minimum
First sale
Nov 23, 2010
As reported in this filing

Fundraising history

Reported sold
Reported amount sold by Form D filing date$0$250K$500KDec 8, 2010: $250,000.00Dec 8, 2010Jan 3, 2011: $500,000.00Jan 3, 2011

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

  • Reported sold$250,000 → $500,000
  • Reported investors1 → 2

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Jan 3, 2011Amendment$500,000$250,000vs Dec 8, 20102SEC filing
Dec 8, 2010Initial$250,000No comparison1SEC filing

Offering details

Securities
Debt, Option to acquire
Exemptions
06
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-151550

Source: Form D, filed Jan 3, 2011. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Francis J. Burrows Executive
Thomas M. Estok Director
Christopher C. Le Masters Director
Gary M. Noonan Director, Executive
Zhong Yin Zhang Director

Issuer details

Industry: Pharmaceuticals (See others in industry)

Address:
351 W. 10 Th Street, Suite 248
Indianapolis, IN, 46202